XVIVO: Heart receives CE marking – key catalyst materialised - Redeye

We view today's CE approval for XVIVO's heart technology very positively, removing one of the key regulatory overhangs in the case and paving the way for a broader commercial launch across Europe. We already include the European heart launch in our estimates and make no changes, but see the announcement as an important de-risking event.

Länk till analysen i sin helhet: https://www.redeye.se/research/1178565/xvivo-heart-receives-ce-marking-key-catalyst-materialised?utm_source=finwire&utm_medium=RSS